This publication summarises an AstraZeneca Medical Affairs educational webinar on transforming asthma care in New Zealand. The session, held in August 2025, was led by Associate Professor Amy Chan who spoke on severe asthma and the oral corticosteroid burden in New Zealand, and by Dr Angela Moran who spoke on clinical implications of high oral corticosteroid use and referral pathways.
Please login below to download this issue (PDF)